SCHEMBL22730167

SCHEMBL22730167

CC(C)(C)[Si](C)(Cl)C(C)(C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 3/20 0.37
TAAR1 Q96RJ0 1/20 0.37
ALOX15 P16050 1/20 0.37
ESR1 P03372 2/20 0.35
ESR2 Q92731 2/20 0.35
CYP3A4 P08684 1/20 0.35
KCNN4 O15554 3/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
CYP2B6 P20813 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10633132 0.91 MAPK1 (0.42) MAPK1TSHRALDH1A1TAAR1ALOX15
SCHEMBL7053156 0.81 ALDH1A1 (0.44) MAPK1TSHRALDH1A1TAAR1ALOX15
SCHEMBL22730152 0.79 CYP2D6 (0.35) MAPK1TSHRALDH1A1TAAR1ALOX15
SCHEMBL22730214 0.79 TAAR1 (0.36) MAPK1TSHRALDH1A1TAAR1ALOX15
SCHEMBL22730170 0.79 TAAR1 (0.36) MAPK1TSHRALDH1A1TAAR1ALOX15
SCHEMBL8741645 0.78 MAPK1 (0.44) MAPK1TSHRALDH1A1TAAR1ALOX15
SCHEMBL22730168 0.77 TAAR1 (0.42) MAPK1TSHRALDH1A1TAAR1ESR1
SCHEMBL10630507 0.76 MAPK1 (0.38) MAPK1TSHRALDH1A1TAAR1ALOX15
SCHEMBL9210673 0.75 MAPK1 (0.46) MAPK1TSHRALDH1A1TAAR1ALOX15
SCHEMBL10633204 0.75 TAAR1 (0.48) MAPK1TSHRALDH1A1TAAR1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066427-B2 Organosilane compounds having bulky substituent and preparation thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-07-20 US disclosed
US-20200385411-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-12-10 US disclosed
EP-3747889-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF Shin-Etsu Chemical Co., Ltd. (JP) 2020-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11066427-B2 Organosilane compounds having bulky substituent and preparation thereof C1S, C1R, C9 MAPK1 2103/4885TSHR 1678/4885ALDH1A1 944/4885
US-20200385411-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF C1S, C1R, C9 MAPK1 2103/4885TSHR 1678/4885ALDH1A1 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.